A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
The New York Times • • general
Key Points:
- At the University of Zambia, students trained as recruiters actively encouraged peers to receive a new H.I.V. prevention injection, highlighting its quick administration and free availability.
- The injection, administered as two shots near the navel, is a cutting-edge drug designed to prevent H.I.V. infection, particularly targeting young African women who are at highest risk.
- This initiative represents an early trial of advanced H.I.V. prevention methods in a region heavily impacted by the virus, aiming to reach those most vulnerable.
- The event was seen as a hopeful development amid challenges faced by Zambia's H.I.V. response, which has been weakened due to changes in foreign aid policies under the Trump administration.